3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Multiple Myeloma
1
Lung Neoplasms
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
venetoclax
4
fludarabine phosphate
3
ibrutinib
2
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
pembrolizumab
1
obinutuzumab
1
ixazomib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carmustine, poliferprosan 20 drug combination
1
auricularum
1
acalabrutinib
1
Tacrolimus
1
RG7388
1
Nivolumab
1
Melphalan
1
Etoposide
1
Dexamethasone
1
Cytarabine
1
Cyclosporins
1
Cyclosporine
1
Cyclophosphamide
1
Carmustine
1
Calcium Dobesilate
1
Bendamustine Hydrochloride
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chromosome 17 deletion
×
Maintenance
×
Clear all
No trials found.